P3 Health Partners Inc. - Class A Common Stock (PIII)
6.7750
-0.1650 (-2.38%)
NASDAQ · Last Trade: Aug 15th, 11:03 PM EDT
Detailed Quote
Previous Close
6.940
Open
6.940
Bid
5.000
Ask
8.320
Day's Range
6.500 - 6.940
52 Week Range
5.800 - 30.49
Volume
9,173
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
11,708
Chart
About P3 Health Partners Inc. - Class A Common Stock (PIII)
P3 Health Partners Inc. is a healthcare organization that focuses on enhancing the quality of care for patients, particularly those within government-sponsored healthcare programs. The company employs a value-based approach to healthcare management, working closely with physicians and healthcare providers to optimize patient outcomes while reducing overall costs. P3 Health Partners leverages innovative technologies and data analytics to improve care coordination, streamline services, and engage patients in their own health journeys, ensuring that individuals receive personalized attention and support throughout their healthcare experiences. Read More
P3 Health Partners (PIII) Q2 2025 earnings miss estimates with $355.8M revenue, but shares rise 7.3% on cost control optimism. Targets 2026 profitability.
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025.
P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, August 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/4:30pm ET the same day.
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2025, and affirmed its 2025 guidance.
P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day.
P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference.
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its 2025 guidance.
P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for the fourth quarter and full year 2024 on March 27, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day.
P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming TD Cowen 45th Annual Health Care Conference in Boston, Massachusetts.
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered, physician-led population health management company, is targeting profitability in 2025, with initial revenue guidance for the year of $1.350 billion to $1.500 billion and Adjusted EBITDA of negative ($35) million to $5 million.
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced it will participate at the upcoming J.P. Morgan Healthcare Conference in San Francisco, California.
